Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ABL1 | P00519 | 1/20 | 0.42 |
| ▸ | RIN1 | Q13671 | 1/20 | 0.42 |
| ▸ | P2RY6 | Q15077 | 4/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.37 |
| ▸ | HTT | P42858 | 1/20 | 0.37 |
| ▸ | P2RY14 | Q15391 | 2/20 | 0.37 |
| ▸ | NT5E | P21589 | 1/20 | 0.37 |
| ▸ | POLB | P06746 | 1/20 | 0.37 |
| ▸ | ADORA3 | P0DMS8 | 3/20 | 0.33 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.33 |
| ▸ | ADORA1 | P30542 | 1/20 | 0.33 |
| ▸ | MAPT | P10636 | 2/20 | 0.33 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.33 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.33 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.33 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.33 |
| ▸ | P2RX3 | P56373 | 1/20 | 0.33 |
| ▸ | MEN1 | O00255 | 1/20 | 0.33 |
| ▸ | NPC1 | O15118 | 1/20 | 0.33 |
| ▸ | RAB9A | P51151 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL26499784 | 0.83 | TMIGD3 (0.36) | ABL1RIN1P2RY6P2RY14NT5E | |
| SCHEMBL1096454 | 0.81 | ABL1 (0.42) | ABL1RIN1P2RY6ALDH1A1HTT | |
| SCHEMBL19814666 | 0.81 | ABL1 (0.42) | ABL1RIN1P2RY6ALDH1A1HTT | |
| SCHEMBL14929222 | 0.81 | ABL1 (0.42) | ABL1RIN1P2RY6ALDH1A1HTT | |
| SCHEMBL19631536 | 0.80 | ABL1 (0.42) | ABL1RIN1P2RY6ALDH1A1HTT | |
| SCHEMBL26499778 | 0.80 | ABL1 (0.36) | ABL1RIN1P2RY6ALDH1A1HTT | |
| SCHEMBL18513393 | 0.79 | ABL1 (0.41) | ABL1RIN1P2RY6ALDH1A1HTT | |
| SCHEMBL7026694 | 0.79 | ABL1 (0.41) | ABL1RIN1P2RY6ALDH1A1HTT | |
| SCHEMBL16512683 | 0.79 | ABL1 (0.39) | ABL1RIN1P2RY6ALDH1A1HTT | |
| SCHEMBL30829089 | 0.79 | ABL1 (0.41) | ABL1RIN1P2RY6ALDH1A1HTT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230322840-A1 | BRIDGED NUCLEOSIDE AND NUCLEOTIDE | LIID PHARMACEUTICALS, INC. (JP) | 2023-10-12 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230322840-A1 | BRIDGED NUCLEOSIDE AND NUCLEOTIDE | NSUN2, RNGTT, RNASEH1 | ABL1 4129/4885RIN1 764/4885P2RY6 753/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.